Have You Heard?

News from the lab, the office—and sometimes the road.

NEWS

Stay Up to Date on FyoniBio

June 2, 2026

FyoniBio to Develop Production Process for PAM Theragnostics’ Lead Compound

PAM Theragnostics Partners with FyoniBio to Establish a Production Process for PAM’s Lead Compound to prevent Alzheimer’s Disease FyoniBio has entered a collaboration with PAM...

March 25, 2026

Propanc and FyoniBio Announce Collaboration on Pharmacokinetics Assay Development

Propanc and FyoniBio Collaborate to Establish and Validate LC-MS-Based Pharmacokinetics Assay for PRP Propanc, a biopharmaceutical company focused on developing novel treatments for chronic diseases,...

October 22, 2025

FyoniBio and INITS Announce Strategic Collaboration

FyoniBio and INITS Join Forces to Provide Biotech Companies with a Fully Integrated Solution from R&D to GMP Clinical Production FyoniBio has entered a strategic...

March 20, 2024

FyoniBio Collaborates with BioLamina and Alder Therapeutics

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications FyoniBio, a specialist in tailored cell line...

February 1, 2024

FyoniBio Received CIR Accreditation

FyoniBio Gains CIR Accreditation to Support French Biopharma Companies FyoniBio has been granted CIR (Crédit d’Impôt Recherche) accreditation through 2025, allowing its French partners to...

May 16, 2023

Strike Pharma and FyoniBio Conclude Successfull Cooperation

FyoniBio and Strike Pharma Successfully Complete Cell Line Development for Bi-specific Antibody Clinical Candidate FyoniBio and Strike Pharma announce the successful completion of a key...

May 16, 2023

FyoniBio Launches Its CHOFlow® Cell Line Technology

FyoniBio Introduces CHOFlow® for High-Yield Production of Afucosylated ADCC-Enhanced Antibodies FyoniBio has launched CHOFlow®—a new addition to its tailored cell line portfolio designed to produce...

January 10, 2023

FyoniBio Collaborates with adivo GmbH

FyoniBio and adivo GmbH Sign a Service Agreement Covering the Generation of a Production Cell Line for Their Canine Therapeutic mAb Candidate FyoniBio and adivo...

October 20, 2022

Strike Pharma and FyoniBio Sign a Master Service Agreement

FyoniBio to Develop Production Cell Line for Strike Pharma’s Novel Bi-Specific Antibody FyoniBio and Strike Pharma have signed a Master Service Agreement to advance the...

June 27, 2022

ProteoNic and FyoniBio Sign a License Agreement for Vector Design

ProteoNic Announces Licensing of Its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio FyoniBio has signed a licensing agreement with ProteoNic, gaining...

Events

Connect with FyoniBio at the Following Events in 2026

Science isn’t static — and neither are we.

You’ll find us at key biotech and pharma events around the world, meeting researchers, exploring new ideas, and talking shop about real-life challenges in biologics development.

Got a project in mind? Stop by our booth, grab a coffee, and let’s talk. Reach out to arrange a meeting.

Nordic Life Science Days

Stockholm, Sweden

8. – 9. September

The 11th Bioproduction Congress

Lyon, France

22. – 23. September

BIOSPAIN

Bilbao, Spain

29. September – 01. October

EU-Japan Biotech & Pharma Partnering Conference

Osaka, Japan

5. – 9. October

BioJapan

Yokohama, Japan

8. – 10. October

Festival of Biologics

Basel, Switzerland

13. – 15. October

Bio-Europe

Cologne, Germany

08. – 11. November

TIDES Europe: Oligonucleotides and Peptide Therapeutics

Amsterdam, Netherlands

03. – 05. November

PEGS Europe | Protein & Antibody Engineering Summit

Lisbon, Portugal

16. – 19. November

European Bioanalysis Forum

Barcelona, Spain

17. – 19. November

We update this section regularly, so feel free to check back from time to time for new materials.

Any questions? Just let us know.